Advertisement
Advertisement
U.S. markets close in 4 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
67.21+0.72 (+1.08%)
As of 11:30AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close66.49
Open67.26
Bid66.70 x 1200
Ask67.25 x 900
Day's Range66.05 - 67.28
52 Week Range37.59 - 102.00
Volume38,660
Avg. Volume285,940
Market Cap1.393B
Beta (5Y Monthly)0.58
PE Ratio (TTM)N/A
EPS (TTM)-5.52
Earnings DateAug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est78.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ENTA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Enanta Pharmaceuticals, Inc.
    ENTA: Raising target price to $48.00ENANTA PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $48.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
Advertisement
Advertisement